MoneyWorks4Me

The Sales for the quarter ended June 2024 of Rs. 788.11 millions rose by 27.02% from Rs. 620.45 millions.Net profit for the quarter ended June 2024 increased significantly by 71.98% to Rs. 41.31 millions from Rs. 24.02 millions.OP of the company witnessed a marginal growth to 104.79 millions from 76.07 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 788.11 620.45 27.02 788.11 620.45 27.02 3490.72 2764.98 26.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 104.79 76.07 37.75 104.79 76.07 37.75 388.98 296.00 31.41
Interest 39.12 26.12 49.77 39.12 26.12 49.77 136.50 92.82 47.06
PBDT 65.67 49.95 31.47 65.67 49.95 31.47 252.48 203.18 24.26
Depreciation 10.47 9.15 14.43 10.47 9.15 14.43 37.96 28.09 35.14
PBT 55.20 40.80 35.29 55.20 40.80 35.29 214.52 175.09 22.52
TAX 13.89 16.78 -17.22 13.89 16.78 -17.22 58.28 67.02 -13.04
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 41.31 24.02 71.98 41.31 24.02 71.98 156.24 108.07 44.57
Equity 46.99 45.80 2.60 46.99 45.80 2.60 46.99 45.32 3.68
PBIDTM(%) 13.30 12.26 8.45 13.30 12.26 8.45 11.14 10.71 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..